Skandinaviska Enskilda Banken (SEB)’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,424
Closed -$80.8K 764
2025
Q3
$80.8K Buy
1,424
+677
+91% +$34.7K ﹤0.01% 748
2025
Q2
$37.3K Buy
747
+600
+408% +$27.1K ﹤0.01% 808
2025
Q1
$4.35K Buy
+147
New +$5.46K ﹤0.01% 825
2024
Q1
Sell
-72,400
Closed -$644K 860
2023
Q4
$644K Buy
72,400
+38,700
+115% +$286K ﹤0.01% 755
2023
Q3
$212K Buy
+33,700
New +$251K ﹤0.01% 831

Other funds holding HIMS

Skandinaviska Enskilda Banken (SEB)'s HIMS Position: Q4 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Hims & Hers Health (HIMS) in Q4 2025, closing a stake of 1,424 shares — an estimated $80.8K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in HIMS in Q3 2023 and held it in 5 quarters. The position peaked at $644K in Q4 2023. 486 funds tracked by Wall St. Rank hold HIMS as of Q4 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Hims & Hers Health position as of Q4 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 1,424 Hims & Hers Health shares in Q4 2025, an estimated $80.8K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Hims & Hers Health in Q3 2023 and held it in 5 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Hims & Hers Health position peaked at $644K in Q4 2023.
  • 486 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2025, filed 12 Feb 2026.